← SynDRA
QUAZINONE
SynDRA canonical compound SYN0004122 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PDE3A | PDE3B |
|---|
| Mechanism of action | phosphodiesterase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- phosphodiesterase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADRB1
- BLM
- CYP1A2
- CYP2C19
- CYP2C9
- CYP2D6
- CYP3A4
- EHMT2
- LMNA
- TSHR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Quazinona
- RO-13-6438/006
- RO-13-6438
- RO-136438
- RO-136438006
- Quazinonum
- D1Q7F6C2FP
- Ro-136438
- Ro 13-6438
- Ro-136438006
- DTXCID4025795
- RefChem:930442
- 6-Chloro-3-methyl-1,5-dihydro-imidazo(2,1-b)quinazolin-2-one
- NCGC00094280-01
- (R)-Quazinone
- Quazinonum [Latin]
- Quazinona [Spanish]
- Quazinone [USAN:INN]
- UNII-D1Q7F6C2FP
- Quazinone, powder
- QUAZINONE [INN]
- Quazinone (USAN/INN)
- QUAZINONE [USAN]
- Lopac-Q-3504
- Ro 13-6438; Ro 13-6438/006
- Lopac0_000980
- SCHEMBL120976
- SCHEMBL120977
- orb1693634
- HMS3263C21
- Tox21_111263
- Tox21_500980
- BDBM50227207
- AKOS040755331
- CCG-205060
- LP00980
- SDCCGSBI-0050953.P002
- NCGC00015875-01
- NCGC00094280-02
Look up QUAZINONE in the interactive SynDRA portal →